Predictive roles of intraoperative blood glucose for posttransplant outcomes in liver transplantation

World Journal of Gastroenterology

Volumn 21, Issue 22, 2015, Pages 6835-6841

  Park, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Blood glucose; Intraoperative; Liver transplantation; Outcome; Prediction

Indexed keywords

ADRENALIN; CORTICOSTEROID; DOPAMINE; GLUCOSE; GLYCOGEN; NORADRENALIN; CATECHOLAMINE DERIVATIVE; VASOACTIVE AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ARTICLE; CRITICALLY ILL PATIENT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCOGEN LIVER LEVEL; GRAFT DYSFUNCTION; GRAFT INFECTION; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTRAOPERATIVE PERIOD; KIDNEY CLEARANCE; KIDNEY FUNCTION; LIVER DISEASE; LIVER TRANSPLANTATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT OUTCOME; BLOOD TRANSFUSION; DIABETIC PATIENT; DISEASE EXACERBATION; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INTENSIVE CARE UNIT; KIDNEY DISEASE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; REFERENCE VALUE; REOPERATION; RETROSPECTIVE STUDY; REVIEW; SURGICAL STRESS; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALYSIS; BLOOD; COMPLICATION; END STAGE LIVER DISEASE; HYPERINSULINISM; INTRAOPERATIVE MONITORING; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR;

BIOMARKERS; BLOOD GLUCOSE; END STAGE LIVER DISEASE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER TRANSPLANTATION; MONITORING, INTRAOPERATIVE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84930861772     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i22.6835     Document Type: Article

References (67)

1. Shangraw RE. Metabolic issues in liver transplantation. Int Anesthesiol Clin 2006; 44: 1-20 [PMID: 16832203 DOI: 10.1097/0 0004311-200604430-00003]
2. Ahmadieh H, Azar ST. Liver disease and diabetes: association, pathophysiology, and management. Diabetes Res Clin Pract 2014; 104: 53-62 [PMID: 24485856 DOI: 10.1016/j.diabres.2014.01.003]
3. Ammori JB, Sigakis M, Englesbe MJ, O'Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 2007; 140: 227-233 [PMID: 17509267 DOI: 10.1016/ j.jss.2007.02.019]
4. Shangraw RE, Hexem JG. Glucose and potassium metabolic responses to insulin during liver transplantation. Liver Transpl Surg 1996; 2: 443-454 [PMID: 9346691 DOI: 10.1002/lt.500020607]
5. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461 [PMID: 16452557 DOI: 10.1056/NEJMoa052521]
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367 [PMID: 11794168 DOI: 10.1056/ NEJMoa011300]
7. Van Herpe T, De Brabanter J, Beullens M, De Moor B, Van den Berghe G. Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms. Crit Care 2008; 12: R24 [PMID: 18302732 DOI: 10.1186/cc6800]
8. Xia VW, Obaidi R, Park C, Braunfeld M, Neelakanta G, Nourmand H, Hu KQ, Steadman RH. Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation. J Cardiothorac Vasc Anesth 2010; 24: 80-83 [PMID: 19362017 DOI: 10.1053/j.jvca.2009.01.032]
9. Park C, Hsu C, Neelakanta G, Nourmand H, Braunfeld M, Wray C, Steadman RH, Hu KQ, Cheng RT, Xia VW. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 2009; 87: 1031-1036 [PMID: 19352123 DOI: 10.1097/ TP.0b013e31819cc3e6]
10. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132: 268-278 [PMID: 17625087 DOI: 10.1378/ chest.06-3121]
11. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114: 1187-1195 [PMID: 15520847 DOI: 10.1172/jci23506]
12. Wintergerst KA, Foster MB, Sullivan JE, Woods CR. Association of hyperglycemia, glucocorticoids, and insulin use with morbidity and mortality in the pediatric intensive care unit. J Diabetes Sci Technol 2012; 6: 5-14 [PMID: 22401317 DOI: 10.1177/193229681 200600102]
13. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010; 112: 860-871 [PMID: 20216389 DOI: 10.1097/ALN]
14. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 2005; 103: 687-694 [PMID: 16192760 DOI: 10.1097/00000542-2005100 00-00006]
15. Song JW, Shim JK, Yoo KJ, Oh SY, Kwak YL. Impact of intraoperative hyperglycaemia on renal dysfunction after off-pump coronary artery bypass. Interact Cardiovasc Thorac Surg 2013; 17: 473-478 [PMID: 23690431 DOI: 10.1093/icvts/ivt209]
16. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009; 8: 13-20 [PMID: 19221528]
17. Keller U, Sonnenberg GE, Burckhardt D, Perruchoud A. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver. J Clin Endocrinol Metab 1982; 54: 961-968 [PMID: 6120952 DOI: 10.1210/jcem-54-5-961]
18. Shangraw RE, Jahoor F. Effect of liver disease and transplantation on urea synthesis in humans: relationship to acid-base status. Am J Physiol 1999; 276: G1145-G1152 [PMID: 10330005]
19. Pfortmueller CA, Wiemann C, Funk GC, Leichtle AB, Fiedler GM, Exadaktylos AK, Lindner G. Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. J Crit Care 2014; 29: 316.e7-316.12 [PMID: 24332992 DOI: 10.1016/j.jcrc.2013.11.002]
20. Erice E, Llop E, Berzigotti A, Abraldes JG, Conget I, Seijo S, Reverter E, Albillos A, Bosch J, García-Pagán JC. Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1458-G1465 [PMID: 22492691]
21. El-Zayadi AR, Anis M. Hepatitis C virus induced insulin resistance impairs response to anti viral therapy. World J Gastroenterol 2012; 18: 212-224 [PMID: 22294824 DOI: 10.3748/wjg.v18.i3.212]
22. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, Moriya K, Koike K. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-848 [PMID: 14988838 DOI: 10.1053/j.gastro.2003.11.056]
23. Banerjee S, Saito K, Ait-Goughoulte M, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. J Virol 2008; 82: 2606-2612 [PMID: 18160431 DOI: 10.1128/jvi.01672-07]
24. Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, Jiang DP, Ide YH, Hotta H. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 2011; 85: 8556-8568 [PMID: 21697492 DOI: 10.1128/jvi.00146-11]
25. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007; 355: 883-888 [PMID: 17331464 DOI: 10.1016/j.bbrc.2007.02.044]
26. Manchanayake J, Chitturi S, Nolan C, Farrell GC. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26: 510-516 [PMID: 21155882 DOI: 10.1111/j.1440-1746.2010.06528. x]
27. Atchison SR, Rettke SR, Fromme GA, Janossy TA, Kunkel SE, Williamson KR, Perkins JD, Rakela J. Plasma glucose concentrations during liver transplantation. Mayo Clin Proc 1989; 64: 241-245 [PMID: 2646482 DOI: 10.1016/S0025-6196(12)65679-1]
28. Stumvoll M, Meyer C, Mitrakou A, Gerich JE. Important role of the kidney in human carbohydrate metabolism. Med Hypotheses 1999; 52: 363-366 [PMID: 10416940 DOI: 10.1054/mehy]
29. Cano N. Inter-relationships between renal metabolism (both in physiology and renal dysfunction) and the liver. Curr Opin Clin Nutr Metab Care 2001; 4: 279-285 [PMID: 11458021 DOI: 10.109 7/00075197-200107000-00006]
30. Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382 [PMID: 1501732 DOI: 10.1159/000186953]
31. Garber AJ, Bier DM, Cryer PE, Pagliara AS. Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis. Diabetes 1974; 23: 982-986 [PMID: 4435312 DOI: 10.2337/diab.23.12.982]
32. Woerle HJ, Meyer C, Popa EM, Cryer PE, Gerich JE. Renal compensation for impaired hepatic glucose release during hypoglycemia in type 2 diabetes: further evidence for hepatorenal reciprocity. Diabetes 2003; 52: 1386-1392 [PMID: 12765948 DOI: 10.2337/diabetes.52.6.1386]
33. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982; 54: 131-138 [PMID: 7033265 DOI: 10.1210/jcem-54-1-131]
34. Nowak G, Ungerstedt J, Wernerman J, Ungerstedt U, Ericzon BG. Metabolic changes in the liver graft monitored continuously with microdialysis during liver transplantation in a pig model. Liver Transpl 2002; 8: 424-432 [PMID: 12004341 DOI: 10.1053/ jlts.2002.32943]
35. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228 [PMID: 23361625 DOI: 10.1007/s00134-012-2769-8]
36. Orban JC, Scarlatti A, Lefrant JY, Molinari N, Leone M, Jaber S, Constantin JM, Allaouchiche B, Ichai C. [Management of glycemia: an audit in 66 ICUs]. Ann Fr Anesth Reanim 2013; 32: 84-88 [PMID: 23337340 DOI: 10.1016/j.annfar.2012.12.002]
37. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297 [PMID: 19318384 DOI: 10.1056/ NEJMoa0810625]
38. Liu LL, Niemann CU. Intraoperative management of liver transplant patients. Transplant Rev (Orlando) 2011; 25: 124-129 [PMID: 21514137 DOI: 10.1016/j.trre.2010.10.006]
39. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15: 353-369 [PMID: 19454396 DOI: 10.4158/ep09102.ra]
40. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005; 33: 1624-1633 [PMID: 16003073 DOI: 10.1097/01. CCM.0000170106.61978.D8]
41. Chen NG, Azhar S, Abbasi F, Carantoni M, Reaven GM. The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers. Atherosclerosis 2000; 152: 203-208 [PMID: 10996356 DOI: 10.1016/ S0021-9150(99)00460-8]
42. Santilli F, Cipollone F, Mezzetti A, Chiarelli F. The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 2004; 36: 319-335 [PMID: 15156413 DOI: 10.1055/ s-2004-814489]
43. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000; 67: 291-300 [PMID: 10983873 DOI: 10.1016/S0024-3205(00)00622-6]
44. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974; 23: 9-15 [PMID: 4809622 DOI: 10.2337/diab.23.1.9]
45. Sima AA, O'Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes 1988; 37: 544-549 [PMID: 3360215 DOI: 10.2337/diab.37.5.544]
46. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995; 123: 919-924 [PMID: 7486486 DOI: 10.7326/0003-481 9-123-12-199512150-00004]
47. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990; 30: 830-832; discussion 832-833 [PMID: 2380999 DOI: 10.1097/00005373-199 007000-00012]
48. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105: 244-252 [PMID: 16871057 DOI: 10.1097/00000542-200608000-00006]
49. Ali NA, O'Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008; 36: 2316-2321 [PMID: 18596625 DOI: 10.1097/CCM.0b013e3181810378]
50. Subramaniam B, Lerner A, Novack V, Khabbaz K, Paryente- Wiesmann M, Hess P, Talmor D. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth Analg 2014; 118: 277-287 [PMID: 24445629 DOI: 10.1213/ane.0000000000000100]
51. Endara M, Masden D, Goldstein J, Gondek S, Steinberg J, Attinger C. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. Plast Reconstr Surg 2013; 132: 996-1004 [PMID: 23783058 DOI: 10.1097/PRS]
52. Park C, Huh M, Steadman RH, Cheng R, Hu KQ, Farmer DG, Hong J, Duffy J, Busuttil RW, Xia VW. Extended criteria donor and severe intraoperative glucose variability: association with reoperation for hemorrhage in liver transplantation. Transplant Proc 2010; 42: 1738-1743 [PMID: 20620513 DOI: 10.1016/j.trans proceed.2009.12.066]
53. Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, Lip H, Post WJ, Slooff MJ. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005; 17: 673-679 [PMID: 15717214 DOI: 10.1007/ s00147-004-0793-5]
54. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804 [PMID: 14578299 DOI: 10.2337/diabetes.52.11.2795]
55. Slaughter TF. Hemostasis and glycemic control in the cardiac surgical patient. Semin Cardiothorac Vasc Anesth 2006; 10: 176-179 [PMID: 16959746 DOI: 10.1177/1089253206288993]
56. Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-780; discussion780 [PMID: 12407365 DOI: 10.1067/msy.2002.128343]
57. Steltzer H, Tüchy G, Hiesmayr M, Müller C, Germann P, Zimpfer M. Peri-operative liver graft function: monitoring using the relationship between blood glucose and oxygen consumption during anaesthesia. Anaesthesia 1992; 47: 955-958 [PMID: 1466435 DOI: 10.1111/j.1365-2044.1992.tb03197.x]
58. Shiba H, Zhu X, Arakawa Y, Irefin S, Wang B, Trenti L, Sanchez IP, Fung JJ, Kelly DM. Glucose balance of porcine liver allograft is an important predictor of outcome. J Surg Res 2011; 171: 851-858 [PMID: 20828723 DOI: 10.1016/j.jss.2010.05.067]
59. Mallett SV, Kang Y, Freeman JA, Aggarwal S, Gasior T, Fortunato FL. Prognostic significance of reperfusion hyperglycemia during liver transplantation. Anesth Analg 1989; 68: 182-185 [PMID: 2643890 DOI: 10.1213/00000539-198902000-00021]
60. Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, Levitsky J. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation 2010; 89: 222-226 [PMID: 20098286 DOI: 10.1097/TP.0b013e3181c3c2ff]
61. Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest 1986; 16: 193-197 [PMID: 3089815 DOI: 10.1111/j.1365-2362.1986.tb01328.x]
62. Konrad T, Golling M, Vicini P, Toffolo G, Wittman M, Mahon A, Klar E, Cobelli C, Usadel K. Insulin sensitivity and beta-cell secretion after liver transplantation in patients with acute liver failure. Transplant Proc 2001; 33: 2576-2579 [PMID: 11406252 DOI: 10.1016/S0041-1345(01)02102-9]
63. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 113: 354-360; discussion 360-362 [PMID: 9040630 DOI: 10.1016/S0022-5223(97)70333-7]
64. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2002; 123: 928-935 [PMID: 12019378 DOI: 10.1067/mtc.2002.121686]
65. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-1021 [PMID: 12771873 DOI: 10.1067/mtc.2003.181]
66. D'Alessandro C, Leprince P, Golmard JL, Ouattara A, Aubert S, Pavie A, Gandjbakhch I, Bonnet N. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007; 134: 29-37 [PMID: 17599483 DOI: 10.1016/j.jtcvs.2007.02.028]
67. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-1502 [PMID: 15006999 DOI: 10.1161/01.cir.0000121747.71054.79]